These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 15160333

  • 1. The association between 3-hydroxy-3-methylglutaryl conenzyme A inhibitor use and breast carcinoma risk among postmenopausal women: a case-control study.
    Boudreau DM, Gardner JS, Malone KE, Heckbert SR, Blough DK, Daling JR.
    Cancer; 2004 Jun 01; 100(11):2308-16. PubMed ID: 15160333
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years.
    Li CI, Malone KE, Weiss NS, Boudreau DM, Cushing-Haugen KL, Daling JR.
    Cancer; 2003 Oct 01; 98(7):1504-13. PubMed ID: 14508839
    [Abstract] [Full Text] [Related]

  • 4. Statin use and breast cancer: prospective results from the Women's Health Initiative.
    Cauley JA, McTiernan A, Rodabough RJ, LaCroix A, Bauer DC, Margolis KL, Paskett ED, Vitolins MZ, Furberg CD, Chlebowski RT, Women's Health Initiative Research Group.
    J Natl Cancer Inst; 2006 May 17; 98(10):700-7. PubMed ID: 16705124
    [Abstract] [Full Text] [Related]

  • 5. Statins and the risk of lung, breast, and colorectal cancer in the elderly.
    Setoguchi S, Glynn RJ, Avorn J, Mogun H, Schneeweiss S.
    Circulation; 2007 Jan 02; 115(1):27-33. PubMed ID: 17179016
    [Abstract] [Full Text] [Related]

  • 6. Absence of an effect of injectable and implantable progestin-only contraceptives on subsequent risk of breast cancer.
    Strom BL, Berlin JA, Weber AL, Norman SA, Bernstein L, Burkman RT, Daling JR, Deapen D, Folger SG, Malone KE, Marchbanks PA, Simon MS, Ursin G, Weiss LK, Spirtas R.
    Contraception; 2004 May 02; 69(5):353-60. PubMed ID: 15105056
    [Abstract] [Full Text] [Related]

  • 7. Statin but not non-statin lipid-lowering drugs decrease fracture risk: a nation-wide case-control study.
    Rejnmark L, Vestergaard P, Mosekilde L.
    Calcif Tissue Int; 2006 Jul 02; 79(1):27-36. PubMed ID: 16868664
    [Abstract] [Full Text] [Related]

  • 8. Long-term use of statins and risk of colorectal cancer: a population-based study.
    Singh H, Mahmud SM, Turner D, Xue L, Demers AA, Bernstein CN.
    Am J Gastroenterol; 2009 Dec 02; 104(12):3015-23. PubMed ID: 19809413
    [Abstract] [Full Text] [Related]

  • 9. Statin use and risk of colorectal cancer.
    Coogan PF, Smith J, Rosenberg L.
    J Natl Cancer Inst; 2007 Jan 03; 99(1):32-40. PubMed ID: 17202111
    [Abstract] [Full Text] [Related]

  • 10. Cigarette smoking and breast cancer.
    Baron JA, Newcomb PA, Longnecker MP, Mittendorf R, Storer BE, Clapp RW, Bogdan G, Yuen J.
    Cancer Epidemiol Biomarkers Prev; 1996 May 03; 5(5):399-403. PubMed ID: 9162307
    [Abstract] [Full Text] [Related]

  • 11. Estrogen receptor-negative breast cancer is less likely to arise among lipophilic statin users.
    Kumar AS, Benz CC, Shim V, Minami CA, Moore DH, Esserman LJ.
    Cancer Epidemiol Biomarkers Prev; 2008 May 03; 17(5):1028-33. PubMed ID: 18463402
    [Abstract] [Full Text] [Related]

  • 12. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
    Rosenberg LU, Einarsdóttir K, Friman EI, Wedrén S, Dickman PW, Hall P, Magnusson C.
    Cancer Epidemiol Biomarkers Prev; 2006 Dec 03; 15(12):2482-8. PubMed ID: 17164374
    [Abstract] [Full Text] [Related]

  • 13. Unopposed estrogen therapy and the risk of invasive breast cancer.
    Chen WY, Manson JE, Hankinson SE, Rosner B, Holmes MD, Willett WC, Colditz GA.
    Arch Intern Med; 2006 May 08; 166(9):1027-32. PubMed ID: 16682578
    [Abstract] [Full Text] [Related]

  • 14. Statins and the risk of acute pancreatitis: a population-based case-control study.
    Thisted H, Jacobsen J, Munk EM, Nørgaard B, Friis S, McLaughlin JK, Sørensen HT, Johnsen SP.
    Aliment Pharmacol Ther; 2006 Jan 01; 23(1):185-90. PubMed ID: 16393296
    [Abstract] [Full Text] [Related]

  • 15. A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk.
    Patel AV, Calle EE, Pavluck AL, Feigelson HS, Thun MJ, Rodriguez C.
    Breast Cancer Res; 2005 Jan 01; 7(6):R1168-73. PubMed ID: 16457697
    [Abstract] [Full Text] [Related]

  • 16. Statin use and the risk of 10 cancers.
    Coogan PF, Rosenberg L, Strom BL.
    Epidemiology; 2007 Mar 01; 18(2):213-9. PubMed ID: 17235211
    [Abstract] [Full Text] [Related]

  • 17. Reproductive factors and breast cancer risk among older women.
    Shantakumar S, Terry MB, Teitelbaum SL, Britton JA, Millikan RC, Moorman PG, Neugut AI, Gammon MD.
    Breast Cancer Res Treat; 2007 May 01; 102(3):365-74. PubMed ID: 17033925
    [Abstract] [Full Text] [Related]

  • 18. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study.
    Swerdlow AJ, Jones ME, British Tamoxifen Second Cancer Study Group.
    J Natl Cancer Inst; 2005 Mar 02; 97(5):375-84. PubMed ID: 15741574
    [Abstract] [Full Text] [Related]

  • 19. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR, Gandhi S, Blasetto J, Heien H, Sasane R, Nelson SP.
    Am J Geriatr Pharmacother; 2007 Sep 02; 5(3):185-94. PubMed ID: 17996658
    [Abstract] [Full Text] [Related]

  • 20. The use of herbal preparations to alleviate climacteric disorders and risk of postmenopausal breast cancer in a German case-control study.
    Obi N, Chang-Claude J, Berger J, Braendle W, Slanger T, Schmidt M, Steindorf K, Ahrens W, Flesch-Janys D.
    Cancer Epidemiol Biomarkers Prev; 2009 Aug 02; 18(8):2207-13. PubMed ID: 19661079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.